首页> Current opinion in pharmacology> The eosinophil as a therapeutic target in asthma: beginning of the end, or end of the beginning?

The eosinophil as a therapeutic target in asthma: beginning of the end, or end of the beginning?

导出 LinkOut

翻译打印收藏纠错

第一作者： Darryl,Adamko

第一单位： Pulmonary Research Group, Department of Medicine, Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta T6G 2S2, Canada.

作者： Darryl,Adamko ^[1] ; Solomon Olawole,Odemuyiwa ; Redwan,Moqbel

作者单位： Pulmonary Research Group, Department of Medicine, Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta T6G 2S2, Canada. ^[1]

医学主题词抗哮喘药(Anti-Asthmatic Agents);哮喘(Asthma);嗜酸细胞(Eosinophils);人类(Humans);炎症(Inflammation);肺(Lung)

DOI 10.1016/s1471-4892(03)00040-7

PMID 12810184

发布时间 2019-11-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览12

Current opinion in pharmacology

2003年3卷3期

227-32页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览12

点击下载本期目录封面

Current opinion in pharmacology

2003年3卷3期

227-32页

检索历史清除

The eosinophil as a therapeutic target in asthma: beginning of the end, or end of the beginning?

Current opinion in pharmacology

相似文献

同项目论文

Current opinion in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The eosinophil as a therapeutic target in asthma: beginning of the end, or end of the beginning?

Current opinion in pharmacology

相似文献

同项目论文

Current opinion in pharmacology

相关期刊

检索历史清除